Practice Locations

UCHealth University of Colorado Hospital (UCH)
12605 E. 16th Ave Aurora, CO 80045

720-848-0000

Zenggang Pan, MD, PhD

Anatomic and Clinical

Board Certified

Zenggang Pan

Care Philosophy

CU Medicine is the largest and most comprehensive multi-specialty physician group practice in the Rocky Mountain region. CU Medicine has over 75 CU Medicine primary and specialty healthcare clinics across Colorado's Front Range and metro Denver. We also offer virtual visits, also known as telehealth or telemedicine.

Title(s)

Professor

Credentials

Doctor of Philosphy Doctor of Medicine

Specialty

Anatomic and Clinical

Scheduling Phone Number

720-848-0000

Gender

Male

Languages

English, Mandarin

Hospital Affiliation

University of Colorado Hospital

Provider Information

  • Anatomic and Clinical (2010)
  • Cancers

    Cancer Pathology , Lymphoma , Myeloma , Leukemia (Adult Acute) , Leukemia (Childhood) , Leukemia (Adult Chronic)

  • Blood / Lymphatic System

    Blood Disorders , Bleeding Disorders

Professor, Pathology

• American Medical Association (AMA), Member • American Society for Clinical Pathology , Member • College of American Pathologists (CAP), Member • United States and Canadian Academy of Pathology (USCAP), Member Colorado Society of Clinical Pathologists, Member

Education and Training

Medical Schools

MD, Peking University Health Science Center (1997)


Graduate Schools

PhD, University of Nebraska Medical Center (2006)


Residency Program

Creighton University Program (2010)


Fellowships

City of Hope National Medical Center Program (2012)

University of Alabama Hospital Program (2011)

Information for referring providers

Referral Contact Phone

720-848-0000

720-848-0000

Referring Patients Link

Information for Referring and Transferring Patients

Clinical Interests for Referring Providers

My major clinical interests include diagnosis of lymphoid and bone marrow disorders, and general surgical pathology.

Research Interest for Referring Providers

My research interests are primarily focused on classification of lymphoid/bone marrow disorders, pathogenesis of the hematologic malignancies, and finding new biomarkers to assistant the diagnosis and therapy for these diseases.